Hyderabad, India, August 1, 2014: Mapmygenome India has partnered with CARE Hospitals Group to offer personal genomics and molecular diagnostics at the hospital. Patients at the CARE can avail of genetic risk prediction tests at the Outpatient Centre in Banjara Hills, Hyderabad.

Ms. Anu Acharya, CEO of Mapmygenome, said, “We are excited about partnering with a progressive group like CARE Hospitals. CARE Hospitals Group with its reputation for transparency, ethical practice and affordability will make personal genomics more reachable to people.”

Mr. DIlip Jose, Group CEO of CARE Hospitals, said, “The partnership with Mapmygenome  is in line with our commitment to make technological advances available to our patients, besides the opportunity to work together on areas of mutual interest in research.”

Dr. Rajeev Menon, Chief of Medical Services at CARE Hospitals commented, “Mapping the genome will help in predicting, preventing and treating a number of diseases. The collaboration will open up new possibilities and help in understanding the gene-disease interaction better”.

About Care Hospitals

The CARE Hospitals Group is a multispecialty healthcare provider, with 15 hospitals serving 9 cities across 6 states of India. The regional leader in tertiary care in South/Central India and among the top 5 pan-Indian hospital chains, CARE Hospitals delivers comprehensive care in more than 30 specialties in tertiary care settings.

For more information, visit: http://www.carehospitals.com.

About Mapmygenome

Mapmygenome is India’s pioneering personal genomics and molecular diagnostics company with a vision to provide “Better Health for Indians using technology.” They offer personal genomics & diagnostic tests, disease detection kits, brain wellness solutions, and counseling services.

They have a range of personal genomics tests that include Genomepatri™ personal genetic profile featuring 100+ conditions and traits; Cardiomap™ genetic test for heart disease, diabetes, and other associated lifestyle conditions; Oncomap™ test for cancer; Brainmap™ genetic test for neuro, psychiatric and cognitive health; Gynaecmap™ test for women; and SMART SPORT™ for sport and fitness ability.. These tests assess not only genetic risks for diseases, traits, and conditions, but also responses to several drugs prescribed for treatment. Counseling services such as genetic counseling and nutrition counseling add value to the tests. Along with their partners in diagnostics and healthcare, Mapmygenome paves way for customers to receive the best attention required to mitigate the risk of diseases.

Mapmygenome offers brain wellness solutions in India under the portfolio Mapmybrain™. This includes MyCalmBeat™ to reduce stress, to improve lung function, and to optimize heartbeat. Another innovative product in this range is WebNeuro™ test to screen cognitive strengths and efficiency.

Mapmygenome also offers Spoligo TB kit for detecting and typing TB. They also have PCR & sequencing molecular diagnostic tests for β-Thalassemia, Hepatitis B, Hepatitis C, and HIV.

Their team at Hyderabad comprises biotechnologists, statisticians, geneticists, bioinformaticians, medical writers, and genetic counselors. Their advisory panel has expert scientists and doctors. In order to enhance this innovative brand and to provide value-added services to customers, their highly skilled research team works on cutting-edge technologies in various domains.

For more information, visit: Mapmygenome